Stock analysts at Roth Capital began coverage on shares of CynergisTek (NYSEAMERICAN:CTEK) in a report issued on Monday. The firm set a “buy” rating and a $7.20 price target on the stock. Roth Capital’s price objective would indicate a potential upside of 48.15% from the company’s previous close.
Separately, Zacks Investment Research downgraded shares of CynergisTek from a “hold” rating to a “sell” rating in a research note on Tuesday, December 19th.
Shares of CynergisTek (NYSEAMERICAN CTEK) traded down $0.14 during trading hours on Monday, hitting $4.86. 25,461 shares of the company were exchanged, compared to its average volume of 34,074. CynergisTek has a 12-month low of $2.70 and a 12-month high of $6.72. The company has a market capitalization of $45.43, a price-to-earnings ratio of 8.24 and a beta of 0.68.
An institutional investor recently raised its position in CynergisTek stock. Perritt Capital Management Inc. raised its holdings in shares of CynergisTek, Inc. (NYSEAMERICAN:CTEK) by 22.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 402,235 shares of the company’s stock after purchasing an additional 74,042 shares during the period. Perritt Capital Management Inc. owned 4.23% of CynergisTek worth $1,629,000 at the end of the most recent reporting period.
CynergisTek Company Profile
Cynergistek, Inc provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients.
Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.